Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with <i>Clostridium difficile</i>—Associated Diarrhea: A Ten-Year Retrospective Analysis

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left"> Inappropriate indication</td><td align="center">Percent of patients</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Indeterminate chest pain</td><td align="center">30.6%</td></tr><tr><td align="left">Nonspecific abdominal pain</td><td align="center">22.6%</td></tr><tr><td align="left">Coprescribed with aspirin</td><td align="center">14.6%</td></tr><tr><td align="left">Coprescribed with low dose steroids</td><td align="center">12.0%</td></tr><tr><td align="left">Coprescribed with warfarin</td><td align="center">10.6%</td></tr><tr><td align="left">Coprescribed with antibiotics</td><td align="center">5.6%</td></tr><tr><td align="left">NPO (nulla per os; nothing by mouth)</td><td align="center">2%</td></tr><tr><td align="left">Nausea</td><td align="center">2%</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Documented inappropriate indications for gastric acid suppression therapy [<a href="/journals/isrn/2012/902320/#B15">7</a>–<a href="/journals/isrn/2012/902320/#B22">14</a>].

International Scholarly Research Notices

tab3

Table 3

Table 3: Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with <i>Clostridium difficile</i>—Associated Diarrhea: A Ten-Year Retrospective Analysis 

Table 3 | Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with Clostridium difficile—Associated Diarrhea: A Ten-Year Retrospective Analysis 